Insider Transactions in Q1 2025 at Lineage Cell Therapeutics, Inc. (LCTX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 11
2025
|
Brian M Culley President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,547
-5.55%
|
$0
$0.65 P/Share
|
|
Feb 11
2025
|
Brian M Culley President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
31,249
+12.14%
|
-
|
|
Feb 11
2025
|
George A. Samuel Iii General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,440
-8.63%
|
$0
$0.65 P/Share
|
|
Feb 11
2025
|
George A. Samuel Iii General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,076
+17.7%
|
-
|
|
Jan 27
2025
|
Broadwood Partners, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Jan 27
2025
|
Broadwood Partners, L.P. Director |
BUY
Open market or private purchase
|
Direct |
7,894,737
+13.74%
|
$0
$0.76 P/Share
|